Sponsored by: Fujifilm

Bracco, Subtle Medical secure CE Mark for AiMIFY software

Bracco

Bracco Diagnostics and Subtle Medical have secured the CE Mark for their collaborative AI-powered software AiMIFY for brain MRI.

AiMIFY uses AI technology to increase the contrast enhancement of brain MRI scans up to twice the level typically achieved with a dose of gadolinium-based contrast agents (GBCAs), according to the two firms.

The companies will begin to prepare to market AiMIFY in Europe, with efforts continuing throughout 2025 and a phased commercial rollout between late 2025 and early 2026, they said.

Page 1 of 621
Next Page